Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
Status:
Withdrawn
Trial end date:
2019-07-26
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine if MEDI8852 administered with standard of care
(oseltamivir) will reduce the time to normalization of respiratory function for adults who
are hospitalized with influenza caused by Type A strains and to determine if MEDI8852 has an
acceptable safety profile in adults who are hospitalized with influenza caused by Type A
strains.